 | PRD_000561 | Name: | FR901277 | Formula: | C47 H63 N9 O13 | Definition date: | 2020-08-12 | Last modified: | 2023-11-03 |
|
 | PRD_002098 | Formula: | C29 H43 N10 O9 | Definition date: | 2013-08-07 | Last modified: | 2023-11-03 |
|
 | PRD_002103 | Name: | L-alpha-glutamyl-L-isoleucyl-N-[(2S,3S)-1-{[(1R)-1-carboxybutyl]amino}-2-hydroxy-5-methylhexan-3-yl]-3-thiophen-2-yl-L-alaninamide | Formula: | C30 H51 N5 O8 S | Definition date: | 2015-07-01 | Last modified: | 2023-11-03 |
|
 | PRD_002107 | Name: | L-alpha-glutamyl-L-isoleucyl-N-[(2S,3S)-4-{[(1S)-1-carboxybutyl]amino}-3-hydroxy-1-(thiophen-2-yl)butan-2-yl]-3-thiophen-2-yl-L-alaninamide | Formula: | C31 H47 N5 O8 S2 | Definition date: | 2015-07-01 | Last modified: | 2023-11-03 |
|
 | PRD_002126 | Name: | N-[4-(benzoylamino)butanoyl]-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-allothreoninamide | Formula: | C38 H54 N7 O10 P | Definition date: | 2014-12-03 | Last modified: | 2023-11-03 |
|
 | PRD_002132 | Name: | (10S,13S,16S,19S)-16-benzyl-12-(N-methyl-L-alanyl-L-valyl)-3,14,17-trioxo-2,7,8,9,12,15,18-heptaazatetracyclo[19.2.2.1~6,9~.1~10,13~]heptacosa-1(23),6(27),7,21,24-pentaene-19-carboxylic acid | Formula: | C37 H47 N9 O7 | Definition date: | 2015-03-04 | Last modified: | 2023-11-03 |
|
 | PRD_002139 | Formula: | C51 H80 N7 O16 P S2 | Definition date: | 2015-02-11 | Last modified: | 2023-11-03 |
|
 | PRD_002148 | Name: | 2-methyl-L-alanyl-N-[(3R,4S,5S)-3-methoxy-1-{(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-{[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino}propyl]pyrrolidin-1-yl}-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide | Formula: | C39 H62 N6 O6 S | Definition date: | 2015-03-25 | Last modified: | 2023-11-03 |
|
 | PRD_002151 | Name: | 2-methyl-L-alanyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S)-1-carboxy-2-phenylethyl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide | Formula: | C37 H61 N5 O8 | Definition date: | 2015-03-25 | Last modified: | 2023-11-03 |
|
 | PRD_002153 | Name: | 2-methyl-L-prolyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S)-1-carboxy-2-phenylethyl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide | Formula: | C39 H63 N5 O8 | Definition date: | 2015-03-25 | Last modified: | 2023-11-03 |
|
 | PRD_002154 | Name: | N,2-dimethyl-L-alanyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S)-1-carboxy-2-phenylethyl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide | Formula: | C38 H63 N5 O8 | Definition date: | 2015-03-25 | Last modified: | 2023-11-03 |
|
 | PRD_002156 | Name: | N-acetyl-L-valyl-L-leucyl-N-[(3R)-7-amino-2-oxoheptan-3-yl]-L-threoninamide | Formula: | C24 H45 N5 O6 | Definition date: | 2016-03-16 | Last modified: | 2023-11-03 |
|
 | PRD_002173 | Name: | N-methyl-L-valyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide | Formula: | C39 H67 N5 O7 | Definition date: | 2016-07-27 | Last modified: | 2023-11-03 |
|
 | PRD_002183 | Name: | (2S,5S,8S,14R,17E)-2-(cyclohexylmethyl)-5-(4-fluorobenzyl)-8-(4-nitrobenzyl)-3,6,9,16,19-pentaoxo-1,4,7,10,15-pentaazacyclononadec-17-ene-14-carboxylic acid | Formula: | C36 H43 F N6 O9 | Definition date: | 2016-09-21 | Last modified: | 2023-11-03 |
|
 | PRD_002204 | Formula: | C21 H34 N4 O7 | Definition date: | 2016-07-27 | Last modified: | 2023-11-03 |
|
 | PRD_002214 | Formula: | C35 H48 N6 O8 | Definition date: | 2015-12-02 | Last modified: | 2023-11-03 |
|
 | PRD_002239 | Name: | N-[5-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl]-L-valyl-L-leucyl-N-[(3R)-7-amino-2-oxoheptan-3-yl]-L-threoninamide | Formula: | C32 H57 N7 O7 S | Definition date: | 2017-08-02 | Last modified: | 2023-11-03 |
|
 | PRD_000641 | Name: | (10R,20R,23R)-10-(4-aminobutyl)-1-[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-20,23-bis(3-carbamimidamidopropyl)-1,8,11,18,21-pentaoxo-2,9,12,19,22-pentaazatetracosan-24-amide | Formula: | C40 H70 N18 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_000642 | Name: | (10R,20R,23R)-1-[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-20,23-bis(3-carbamimidamido
propyl)-10-methyl-1,8,11,18,21-pentaoxo-2,9,12,19,22-pentaazatetracosan-24-amide | Formula: | C37 H63 N17 O9 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_000645 | Name: | (2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-N-(6-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]amino}-6-oxohexyl)-3,4-dihydroxytetrahydrofuran-2-carboxamide | Formula: | C28 H47 N15 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
 | PRD_002256 | Name: | N-tert-butoxy-N~2~-(5-methyl-1,2-oxazole-3-carbonyl)-L-asparaginyl-O-methyl-N-[(naphthalen-1-yl)methyl]-L-serinamide | Formula: | C28 H35 N5 O7 | Definition date: | 2017-01-11 | Last modified: | 2023-11-03 |
|
 | PRD_002257 | Name: | Globomycin | Formula: | C32 H57 N5 O9 | Definition date: | 2019-08-28 | Last modified: | 2023-11-03 |
|
 | PRD_002282 | Name: | (3S,6S,9S,15aR)-6,9-dibenzyl-3-{6,6-dihydroxy-6-[(2S)-oxiran-2-yl]hexyl}octahydro-2H-pyrido[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10(3H,12H)-tetrone | Formula: | C34 H44 N4 O7 | Definition date: | 2017-09-13 | Last modified: | 2023-11-03 |
|
 | PRD_002285 | Name: | N~2~-[(2S)-2-{[3-(6-chloro-1,3-benzothiazol-2-yl)-N-propanoyl-L-alanyl]amino}-2-cyclopentylacetyl]-N-[(4R)-3,4-dihydro-2H-1-benzopyran-4-yl]-N~6~,N~6~-dimethyl-L-lysinamide | Formula: | C37 H49 Cl N6 O5 S | Definition date: | 2018-02-28 | Last modified: | 2023-11-03 |
|
 | PRD_000672 | Name: | CBZ-ASP-GLU-VAL-azaASP-EP-CO-NH-CH2PH | Formula: | C35 H44 N6 O14 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|